MedTrace Logo

Efficacy and Tolerability of Balneotherapy With Mineral Water Named" Debole of Vetriolo" in Fibromyalgia Syndrome

NCT02548065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-01-31

No results posted yet for this study

Summary

The present randomized, controlled double blind trial aims to evaluate the efficacy and tolerability of balneotherapy with mineral water named "Debole of Vetriolo" in 100 patients with primary Fibromyalgia Syndrome (FS).

Conditions

  • Fibromyalgia Syndrome

Interventions

OTHER

Balneotherapy

Bath with mineral water named "Debole of Vetriolo" at 36°C, 15 minutes for 12 consecutive days in bathtubs

OTHER

Placebo

Bath with Thermal tap water

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Senese

    lead OTHER

Principal Investigators

  • Antonella Fioravanti, MD · Azienda Ospedaliera Universitaria Senese

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2016-10-31
Completion
2017-01-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02548065 on ClinicalTrials.gov